Application is a critical axis in Bone Marrow Aspiration Biopsy Needle Kit segmentation, with three primary domains driving market demand. First, hematological disorder diagnosis constitutes the largest share, accounting for ~45% of procedural usage, driven by leukemia, lymphoma, and myeloma cases. Second, cancer staging and metastasis evaluation represents ~35% of applications, particularly in oncology departments leveraging marrow biopsies for prognosis and treatment planning. Third, infectious disease diagnostics (e.g., tuberculosis, fungal infections) and bone marrow failure syndromes (e.g., aplastic anemia) contribute ~20%, supported by rising autoimmune and metabolic disease prevalence. These applications collectively shape the market size by reflecting unmet clinical needs and technological advancements in needle design for precision and patient comfort.